Discordance between nurse practitioner– or physician associate–reported and patient-reported atopic dermatitis severity and satisfaction with disease control and the relationship with patient-reported outcomes
Background: Data are limited on how nurse practitioners (NPs) and physician assistants (PAs) assess atopic dermatitis (AD) severity and treatment satisfaction and how their assessments compare to patient assessments. Purpose: To assess discordance between NPs or PAs and patients on assessments of AD severity and satisfaction with disease control, and relationship of discordance with patient-reported outcomes (PROs). Methodology: Data were collected from Adelphi Real World AD advanced practice providers Disease Specific Programme, a cross-sectional, real-world observational survey conducted in the United States from 2021 to 2022. Analysis included 87 NPs and PAs in dermatologist/allergist settings and 187 adult patients with current/history of moderate or severe AD. For each patient, NP or PA completed a form measuring subjective AD severity and satisfaction with disease control. Patients independently reported subjective assessments and completed validated PROs. Results: Among patient–NP and patient–PA dyads, 66% agreed on AD severity; in 22% of these dyads, NPs or PAs rated AD severity higher than the patient. Agreement on satisfaction with disease control occurred in 75% of dyads. Among those who disagreed, 17% of patients were more satisfied than NPs or PAs. Agreement on disease progression occurred in 57% of dyads. Discordant dyads were more likely to involve patients experiencing a flare, as assessed by NP or PA, and reporting greater PRO impairments. Conclusions: Most patient-NP and patient-PA dyads were concordant in AD assessments; however, a considerable proportion showed discordance. Discordance tended to be related to worse PROs. Implications: Alignment between patients and NPs or PAs in AD perceptions may improve outcomes.
Authors
- James Piercy (ORCID: https://orcid.org/0000-0001-7015-1021)
- Simran Marwaha (ORCID: https://orcid.org/0000-0003-0380-0372)
- Amber Reck Atwater (ORCID: https://orcid.org/0000-0001-7434-0014)
- Lakshi M. Aldredge (ORCID: https://orcid.org/0000-0003-3675-1917)
- Evangeline J. Pierce (ORCID: https://orcid.org/0000-0002-8287-2835)
- Wendy Cantrell
- Zach Dawson (ORCID: https://orcid.org/0009-0003-9511-4640)
- Melissa M. Davis
- Peter Anderson (ORCID: https://orcid.org/0000-0002-2171-8228)
- Matthew Reynolds
Institutions
- Eli Lilly (United States) (US)
- Adelphi Group (United Kingdom) (GB)
- VA Portland Health Care System (US)
- Associates in Neurology (US)
Publication Details
- Journal
- Journal of the American Association of Nurse Practitioners
- Published
- 2026-11-19
- DOI
- https://doi.org/10.1097/jxx.0000000000001373
- Primary Topic
- Dermatology and Skin Diseases
- Type
- article
- Field-Weighted Citation Impact
- 0.00